Raleigh, North Carolina, United States Related Funds
| Fund Name | Location |
| Acacia Institutional Partners | - |
| Aviva Investors | England, London, United Kingdom |
| BANK IM BISTUM ESSEN eG | Essen, Germany, Nordrhein-Westfalen |
| buebull ventures | - |
| Bull Creek Capital | Austin, Texas, United States |
| Fenghui Consulting | China, Hangzhou, Zhejiang |
| GRA Venture Fund, LLC | Atlanta, Georgia, United States |
| igniteXL Ventures | California, Palo Alto, United States |
| Jinhua Aoxiang | China, Hangzhou, Zhejiang |
| Kyushu Kizuna Capital | Japan, Kumamoto, Kumamoto Prefecture |
| Lanxum | Beijing, Beijing, China |
| NextView Ventures | Boston, Massachusetts, United States |
| Pacifica Fund | California, Palo Alto, United States |
| Queen City Angels | Cincinnati, Ohio, United States |
| Renhe Automobile Service | China, Ningbo, Zhejiang |
| Suzhou Nongfa Chuangxin | China, Jiangsu, Suzhou |
| Third Wave Ventures | Beverly Hills, California, United States |
| Xian Haichuang Zhixing Chuangye Touzi | China, Shaanxi, Xian Shi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
410 Medical | $7M | 25 May 2023 | Durham, North Carolina, United States | ||
410 Medical | $6M | 10 Nov 2022 | Durham, North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
410 Medical | $7M | 25 May 2023 | Durham, North Carolina, United States | ||
410 Medical | $6M | 10 Nov 2022 | Durham, North Carolina, United States |
